223 related articles for article (PubMed ID: 26231412)
21. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies.
Abel A; Lazaro E; Ralazamahaleo M; Pierrisnard E; Suzon B; Bonnet F; Mercié P; Macey J; Agossou M; Viallard JF; Deligny C; Rivière E
Eur J Intern Med; 2023 Sep; 115():104-113. PubMed ID: 37330316
[TBL] [Abstract][Full Text] [Related]
22. [Antisynthetase syndrome. Three cases and a review of the literature].
Imbert-Masseau A; Hamidou M; Agard C; Halloun A; Delangle MH; Audrain M; Grolleau JY; Mussini JM
Ann Med Interne (Paris); 2003 Nov; 154(7):483-8. PubMed ID: 14732841
[TBL] [Abstract][Full Text] [Related]
23. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
24. The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome.
Yousem SA; Schneider F; Bi D; Oddis CV; Gibson K; Aggarwal R
Hum Pathol; 2014 Jun; 45(6):1199-204. PubMed ID: 24767252
[TBL] [Abstract][Full Text] [Related]
25. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
Pinal-Fernandez I; Casal-Dominguez M; Huapaya JA; Albayda J; Paik JJ; Johnson C; Silhan L; Christopher-Stine L; Mammen AL; Danoff SK
Rheumatology (Oxford); 2017 Jun; 56(6):999-1007. PubMed ID: 28339994
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival.
Hervier B; Meyer A; Dieval C; Uzunhan Y; Devilliers H; Launay D; Canuet M; Têtu L; Agard C; Sibilia J; Hamidou M; Amoura Z; Nunes H; Benveniste O; Grenier P; Montani D; Hachulla E
Eur Respir J; 2013 Nov; 42(5):1271-82. PubMed ID: 23397301
[TBL] [Abstract][Full Text] [Related]
27. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome.
Schneider F; Aggarwal R; Bi D; Gibson K; Oddis C; Yousem SA
Arch Pathol Lab Med; 2015 Jan; 139(1):122-5. PubMed ID: 25549148
[TBL] [Abstract][Full Text] [Related]
28. Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
Rivero-Gallegos D; Mejía M; Rocha-González HI; Huerta-Cruz JC; Falfán-Valencia R; Ramos-Martínez E; Mateos-Toledo HN; Castillo-López MF; Rodríguez-Torres YK; Lira-Boussart V; Rojas-Serrano J
Clin Rheumatol; 2024 Jun; 43(6):1971-1978. PubMed ID: 38642252
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
[TBL] [Abstract][Full Text] [Related]
30. [Diffuse infiltrating lung disease secondary to antisynthetase syndrome: a case report].
Moussa N; Khemakhem R; Snoussi M; Fekih W; Bahloul Z; Kammoun S
Pan Afr Med J; 2021; 39():30. PubMed ID: 34394821
[TBL] [Abstract][Full Text] [Related]
31. Antisynthetase syndrome: Analysis of 11 cases.
Zamarrón-de Lucas E; Gómez Carrera L; Bonilla G; Petit D; Mangas A; Álvarez-Sala R
Med Clin (Barc); 2017 Feb; 148(4):166-169. PubMed ID: 28073522
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations and treatment of antisynthetase syndrome.
Marco JL; Collins BF
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101503. PubMed ID: 32284267
[TBL] [Abstract][Full Text] [Related]
33. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
[TBL] [Abstract][Full Text] [Related]
34. [Antisynthetase syndrome with pulmonary hypertension: 4 original observations].
Lecomte R; Perrin F; Journeau L; Espitia O; Piriou N; Horeau-Langlard D; Néel A; Masseau A; Hamidou M; Agard C
Rev Med Interne; 2015 Dec; 36(12):794-9. PubMed ID: 25895991
[TBL] [Abstract][Full Text] [Related]
35. [Antisynthetase syndrome and lung carcinoma: a fortuitous association?].
Courties A; Lidove O; Maisonobe T; Rigolet A; Hermet A; Girard P; Ziza JM
Rev Med Interne; 2014 Apr; 35(4):271-3. PubMed ID: 23726930
[TBL] [Abstract][Full Text] [Related]
36. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
[TBL] [Abstract][Full Text] [Related]
37. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
[TBL] [Abstract][Full Text] [Related]
38. [Acute respiratory distress revealing antisynthetase syndrome].
Maloir Q; Ghysen K; von Frenckell C; Louis R; Guiot J
Rev Med Liege; 2018 Jul; 73(7-8):370-375. PubMed ID: 30113776
[TBL] [Abstract][Full Text] [Related]
39. Clinical heterogeneity and outcomes of antisynthetase syndrome.
Hervier B; Benveniste O
Curr Rheumatol Rep; 2013 Aug; 15(8):349. PubMed ID: 23794106
[TBL] [Abstract][Full Text] [Related]
40. Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances.
Hallowell RW; Danoff SK
Curr Opin Rheumatol; 2014 Nov; 26(6):684-9. PubMed ID: 25203119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
